RecruitingNCT02770066

A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension

A Prospective Danish National Registry of Percutaneous Transluminal Renal Angioplasty in Patients With Renovascular Hypertension


Sponsor

University of Aarhus

Enrollment

160 participants

Start Date

Jan 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

A prospective Danish national registry of percutaneous transluminal renal angioplasty (PTRA) in high-risk patients with renal artery stenosis selected on the basis of common national criteria, and with a common follow-up protocol for all three Danish centres offering PTRA


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is tracking Danish patients with high blood pressure caused by narrowed kidney arteries (renovascular hypertension) who underwent a procedure called PTRA (a balloon-based treatment to open the blocked artery) to monitor how well their blood pressure is controlled afterward. **You may be eligible if...** - You have high blood pressure that does not respond to three or more blood pressure medications at full doses, including a water pill (diuretic) - Your uncontrolled blood pressure has been confirmed by a 24-hour blood pressure monitor worn throughout the day - Your average 24-hour systolic blood pressure (the top number) is at or above 130 mmHg - OR you have high blood pressure but cannot tolerate blood pressure medications due to side effects **You may NOT be eligible if...** - Your blood pressure is adequately controlled on your current medications - You do not have narrowed kidney arteries identified as the cause of your hypertension - You are not a candidate for the kidney artery procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPercutaneous transluminal renal angioplasty

Angioplasty plus stenting (angioplasty in patients with fibromuscular dysplasia) Adjuvant therapy in atherosclerotic renal artery stenosis - at the discretion of the treating physician * Antiplatelet therapy (usually standard) * Cholesterol-lowering drugs (usually standard) * Antihypertensive treatment with angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (normally not contraindicated) * Smoking cessation, diet and physical activity (usually standard)


Locations(5)

Aalborg University Hospital

Aalborg, Denmark

Aarhus University Hospital

Aarhus N, Denmark

Glostrup University Hospital/ Rigshospitalet

Glostrup Municipality, Denmark

Holbaek Hospital

Holbæk, Denmark

Odense University Hospital

Odense C, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02770066


Related Trials